Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...
Herc Holdings is set for growth with capital plans and strong cash flows. Find out why HERC stock is a solid buy in renewable ...
Revenues for the first fiscal quarter of 2025 were $13.7 million, compared to $16.9 million in the first fiscal quarter of 2024, a decrease of 19%. The decrease in revenue for the year was due to ...
Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...
Q4 2024 Management View CEO Martin Lyons highlighted strong operational and financial results for 2024, including adjusted earnings of $4.63 per share, exceeding the midpoint of their guidance range.
THE WEEK'S TOP-SELLING CURRENT ALBUMS (LESS THAN 18 MONTHS OLD) ACROSS ALL GENRES, AS COMPILED BY LUMINATE. The Weeknd New this week! XO/Republic Highest ranking debut Gains In Performance Week of ...